Important differences between topoisomerase-I and -II targeting agents

被引：11

作者：

Banerji, Shantanu ^{[1
]}

Los, Marek ^{[1
]}

机构：

[1] Manitoba Inst Cell Biol, Canada Res Chair Canc Therapy Dev, Winnipeg, MB R3E 0V9, Canada

来源：

CANCER BIOLOGY & THERAPY | 2006年 / 5卷 / 08期

关键词：

mitoxantrone; topotecan; topoisomerase targeting agents; reactive oxygen species (ROS); X2HS;

D O I：

10.4161/cbt.5.8.3274

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：965 / 966

页数：2

共 20 条

[1] Guiding ATM to broken DNA [J].

Abraham, RT ;

Tibbetts, RS .

SCIENCE, 2005, 308 (5721) :510-511

[2]

Banáth JP, 2003, CANCER RES, V63, P4347

[3]

Burma S, 2001, J BIOL CHEM, V276, P42462, DOI 10.1074/jbc.C100466200

[4]

DOROSHOW JH, 2006, CANC CHEMOTHERAPY BI

[5]

HSIANG YH, 1988, CANCER RES, V48, P1722

[6]

HSIANG YH, 1989, CANCER RES, V49, P5077

[7]

HSIANG YH, 1985, J BIOL CHEM, V260, P4873

[8] Activation of ATM and histone H2AX phosphorylation induced by mitoxantrone but not by topotecan is prevented by the antioxidant N-acetyl-L-cysteine [J].

Huang, Xuan ;

Kurose, Akira ;

Tanaka, Toshiki ;

Traganos, Frank ;

Dai, Wei ;

Darzynkiewicz, Zbigniew .

CANCER BIOLOGY & THERAPY, 2006, 5 (08) :959-964

[9] Doxorubicin activates ATM-dependent phosphorylation of multiple downstream targets in part through the generation of reactive oxygen species [J].

Kurz, EU ;

Douglas, P ;

Lees-Miller, SP .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (51) :53272-53281

[10] Reactive oxygen species elicit apoptosis by concurrently disrupting topoisomerase II and DNA-dependent protein kinase [J].

Lu, HR ;

Zhu, H ;

Huang, M ;

Chen, Y ;

Cai, YJ ;

Miao, ZH ;

Zhang, JS ;

Ding, J .

MOLECULAR PHARMACOLOGY, 2005, 68 (04) :983-994

← 1 2 →